Clinical Trial Update: Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 2/3 clinical trial evaluating neoadjuvant endocrine therapy in HR-positive, HER2-negative premenopausal breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED